BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 19996206)

  • 1. Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer.
    Jorissen RN; Gibbs P; Christie M; Prakash S; Lipton L; Desai J; Kerr D; Aaltonen LA; Arango D; Kruhøffer M; Orntoft TF; Andersen CL; Gruidl M; Kamath VP; Eschrich S; Yeatman TJ; Sieber OM
    Clin Cancer Res; 2009 Dec; 15(24):7642-7651. PubMed ID: 19996206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature.
    Thorsteinsson M; Kirkeby LT; Hansen R; Lund LR; Sørensen LT; Gerds TA; Jess P; Olsen J
    Int J Colorectal Dis; 2012 Dec; 27(12):1579-86. PubMed ID: 22710688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].
    Fan YZ; Li XP; Liu WF; Li GM
    Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.
    Arango D; Laiho P; Kokko A; Alhopuro P; Sammalkorpi H; Salovaara R; Nicorici D; Hautaniemi S; Alazzouzi H; Mecklin JP; Järvinen H; Hemminki A; Astola J; Schwartz S; Aaltonen LA
    Gastroenterology; 2005 Sep; 129(3):874-84. PubMed ID: 16143127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 19-Gene expression signature as a predictor of survival in colorectal cancer.
    Abdul Aziz NA; Mokhtar NM; Harun R; Mollah MM; Mohamed Rose I; Sagap I; Mohd Tamil A; Wan Ngah WZ; Jamal R
    BMC Med Genomics; 2016 Sep; 9(1):58. PubMed ID: 27609023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
    Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
    PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of high-risk Dukes B colorectal cancer by microRNA expression profiling: a preliminary study.
    Aslam MI; Venkatesh J; Jameson JS; West K; Pringle JH; Singh B
    Colorectal Dis; 2015 Jul; 17(7):578-88. PubMed ID: 25557290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer.
    Zhang H; Sun XF
    Int J Oncol; 2001 Jul; 19(1):49-52. PubMed ID: 11408921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging?
    Cianchi F; Messerini L; Palomba A; Boddi V; Perigli G; Pucciani F; Bechi P; Cortesini C
    Dis Colon Rectum; 1997 Oct; 40(10):1170-5; discussion 1175-6. PubMed ID: 9336111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
    Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
    Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
    Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
    Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.
    Zieglschmid V; Hollmann C; Mannel J; Albert W; Jaeschke-Melli S; Eckstein B; Hillemann T; Greten TF; Gross E; Böcher O
    Anticancer Res; 2007; 27(4A):1823-32. PubMed ID: 17649779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
    Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
    Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression signature predicts recurrence in lung adenocarcinoma.
    Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
    Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.